These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31486736)

  • 1.
    Rooney SR; Shelton EL; Aka I; Shaffer CM; Clyman RI; Dagle JM; Ryckman K; Lewis TR; Reese J; Van Driest SL; Kannankeril PJ
    Pharmacogenomics; 2019 Aug; 20(13):939-946. PubMed ID: 31486736
    [No Abstract]   [Full Text] [Related]  

  • 2. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
    Malviya M; Ohlsson A; Shah S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003951. PubMed ID: 18254035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003481. PubMed ID: 18254020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
    Malviya M; Ohlsson A; Shah S
    Cochrane Database Syst Rev; 2003; (3):CD003951. PubMed ID: 12917997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.
    Ohlsson A; Walia R; Shah SS
    Cochrane Database Syst Rev; 2015 Feb; (2):CD003481. PubMed ID: 25692606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.
    Ohlsson A; Walia R; Shah SS
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD003481. PubMed ID: 30264852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003481. PubMed ID: 16235321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in CYP2C9 are associated with response to indomethacin among neonates with patent ductus arteriosus.
    Smith CJ; Ryckman KK; Bahr TM; Dagle JM
    Pediatr Res; 2017 Nov; 82(5):776-780. PubMed ID: 28609430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants.
    Ohlsson A; Shah PS
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD010061. PubMed ID: 31985831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indomethacin for symptomatic patent ductus arteriosus in preterm infants.
    Evans P; O'Reilly D; Flyer JN; Soll R; Mitra S
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013133. PubMed ID: 33448032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of PDA Treatment in Preterm Neonates Who Had Received Prophylactic Indomethacin.
    Louis D; ElSayed YN; Ojah C; Alvaro R; Shah PS; Dunn M;
    Am J Perinatol; 2018 Apr; 35(5):509-514. PubMed ID: 29183097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Shah SS
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004213. PubMed ID: 31985838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.
    Ohlsson A; Walia R; Shah SS
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD003481. PubMed ID: 32045960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2003; (2):CD003481. PubMed ID: 12804469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
    Malviya MN; Ohlsson A; Shah SS
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD003951. PubMed ID: 23543527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Therapeutic Response to Cyclooxygenase Inhibitors in Preterm Infants with Patent Ductus Arteriosus.
    Hu Y; Jin H; Jiang Y; Du J
    Pediatr Cardiol; 2018 Apr; 39(4):647-652. PubMed ID: 29468349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates.
    El-Mashad AE; El-Mahdy H; El Amrousy D; Elgendy M
    Eur J Pediatr; 2017 Feb; 176(2):233-240. PubMed ID: 28004188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor polymorphism rs2010963 status does not affect patent ductus arteriosus incidence or cyclooxygenase inhibitor treatment success in preterm infants.
    Sallmon H; Aydin T; Hort S; Kubinski A; Bode C; Klippstein T; Endesfelder S; Bührer C; Koehne P
    Cardiol Young; 2019 Jul; 29(7):893-897. PubMed ID: 31218973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah SS
    Cochrane Database Syst Rev; 2013 Apr; (4):CD003481. PubMed ID: 23633310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-type natriuretic peptide predicts responses to indomethacin in premature neonates with patent ductus arteriosus.
    Hsu JH; Yang SN; Chen HL; Tseng HI; Dai ZK; Wu JR
    J Pediatr; 2010 Jul; 157(1):79-84. PubMed ID: 20227723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.